Anne Arundel Health System Research Institute Report issue

Academic/Hospital Phase 2 Phase 3

Organization Overview

First Clinical Trial
2012
NCT01490502
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Anne Arundel Health System Research Institute | Anne Arundel Health System Research Institute (AAHS)

Active Ingredients

Drugs in Phase 3 Trials (1)

vitamin d3 (1 trial)

Drugs in Phase 2 Trials (1)

paclitaxel (taxol) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Breast Neoplasms (Phase 2)

Multiple Sclerosis (Phase 3)

Multiple Sclerosis, Relapsing-Remitting (Phase 3)

Sclerosis (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 2